现代中西医治疗卵巢癌的应用及研究进展
Application and Research Progress of Modern Chinese and Western Medicine in the Treatment of Ovarian Cancer
DOI: 10.12677/tcm.2024.1310394, PDF,   
作者: 刘馨月:黑龙江中医药大学,黑龙江 哈尔滨;刘松江*:黑龙江中医药大学附属第一医院,黑龙江 哈尔滨
关键词: 卵巢癌癥瘕中西医妇科疾病Ovarian Cancer Targeted Illness Chinese and Western Medicine Gynecological Diseases
摘要: 卵巢癌是妇科恶性肿瘤中发病率最高的一种,死亡率居妇女恶性肿瘤之首,严重危害妇女健康。在原发性卵巢肿瘤中,上皮性卵巢癌(EOC)发病率高达85%~95%。卵巢的位置较深,早期表现不明显,不易被察觉,其早期检出率只有15%左右,大多是在进入晚期时才被诊断。根据目前的数据,卵巢上皮癌患者的5年存活率仅有40%。由于缺乏有效的早期诊断手段,多数卵巢癌被确诊时已是中、晚期,现有的常规治疗措施疗效不佳,死亡率极高。目前,早期卵巢癌患者首选手术治疗,术后辅以化学治疗和放射治疗。目前,临床上对上皮性卵巢癌的治疗以手术 + 放化疗为主。化学疗法是目前临床上最主要的治疗方法,但是随着治疗的不断深化与发展,化疗药物的副作用以及人体产生的耐药性也越来越突出。本文就现代中西医治疗卵巢癌的应用及研究进展进行论述,为此病的防治提供参考。
Abstract: Ovarian cancer is one of the most common gynecological malignancies with the highest incidence rate. Its mortality rate ranks first among women’s malignancies, which seriously endangers women’s health. Among primary ovarian tumors, the incidence rate of epithelial ovarian cancer (EOC) is as high as 85%~95%. The position of the ovary is relatively deep, and its early manifestations are not obvious and difficult to detect. Its early detection rate is only about 15%, and it is mostly diagnosed in the late stage. According to current data, the 5-year survival rate for ovarian epithelial cancer patients is only 40%. Due to the lack of effective early diagnostic methods, most ovarian cancers are diagnosed in the middle or late stages, and existing conventional treatment measures have poor efficacy and extremely high mortality rates. At present, surgery is the preferred treatment for early ovarian cancer patients, supplemented by chemotherapy and radiation therapy after surgery. At present, the main treatment for epithelial ovarian cancer in clinical practice is surgery + radiotherapy and chemotherapy. Chemotherapy is currently the most important treatment method in clinical practice, but with the continuous deepening and development of treatment, the side effects of chemotherapy drugs and the development of drug resistance in the human body have become increasingly prominent. This article discusses the application and research progress of modern Chinese and Western medicine in the treatment of ovarian cancer, providing reference for the prevention and treatment of this disease.
文章引用:刘馨月, 刘松江. 现代中西医治疗卵巢癌的应用及研究进展[J]. 中医学, 2024, 13(10): 2646-2651. https://doi.org/10.12677/tcm.2024.1310394

参考文献

[1] 王铭远, 汤小晗, 卢美松. 妇科常见恶性肿瘤中自噬的研究进展[J]. 国际妇产科学杂志, 2017, 44(1): 5-8.
[2] 邹文燕, 钱志红, 徐惠民. 树突状细胞与卵巢癌的免疫治疗[J]. 国外医学(妇产科学分册), 2003, 30(1): 50-53
[3] 杨林林, 柏明珠, 吴煜, 等. 促排卵药物与卵巢癌关系的研究进展[J]. 现代生物医学进展, 2018, 18(2): 377-380.
[4] 崔昌浩, 邓营营, 王黎, 等. 一种细胞分裂素通过抑制DNA聚合酶活性抑制细胞增殖的方法[P]. 中国专利, CN201811213728.7. 2024-09-13.
[5] 赵燕, 赵莹, 王绪成. 靶向给药在肿瘤治疗中的应用进展[J]. 中国医院用药评价与分析, 2008, 8(1): 8-11.
[6] M∙马塔, Y∙比利亚尔, M∙卡拉. 病毒载体及其在细胞过继疗法中的用途[P]. 中国专利, CN202080039116.X. 2024-09-13.
[7] 占义平, 叶丽红. 卵巢癌中医药研究近况[J]. 辽宁中医药大学学报, 2013, 15(2): 218-220.
[8] 付艳, 王晓京, 肖文华, 等. 复方苦参注射液用于化疗的观察[J]. 中国医院用药评价与分析, 2008, 8(5): 384-385.
[9] 周小祝, 莫志贤. 桂枝茯苓丸的药理作用研究进展[J]. 医药导报, 2006, 25(2): 142-143.
[10] 唐朝朗. 薯蓣丸浅析与临床运用[J]. 医药与保健, 2016, 24(5): 82-83.
[11] 赵惠. 紫杉醇为主的化疗药学监护[J]. 河北医药, 2013, 35(10): 1565-1566.
[12] 郑耀庭. 山东省针灸教育与临床现状分析及对策研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2009.
[13] 张傲. 中药泥灸治疗寒凝血瘀型卵巢癌腹痛的临床疗效观察[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2021.